THE EFFICACY AND SAFETY OF MIRABEGRON RELATIVE TO ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER NOT APPROPRIATELY MANAGED WITH AN ANTIMUSCARINIC: A NETWORK META-ANALYSIS

被引：1
|
作者：
Lozano-Ortega, G. [1 ]
Gooch, K. [2 ]
Walker, D. [3 ]
Rogula, B. [1 ]
Deighton, A. [1 ]
Johnston, K. M. [1 ]
Dmochowski, R. [4 ]
机构：
[1] Broadst Hlth Econ & Outcomes Res, Vancouver, BC, Canada
[2] Astellas Pharma Global Dev Inc, Northbrook, IL USA
[3] Astellas, Northbrook, IL USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1796
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK2
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [1] The Relative Efficacy and Safety of Mirabegron and OnabotulinumtoxinA in Patients With Overactive Bladder who Have Previously Been Managed With an Antimuscarinic: A Network Meta-analysis
    Lozano-Ortega, Greta
    Walker, David
    Rogula, Basia
    Deighton, Alison
    Johnston, Karissa
    Hawkins, Neil
    Dmochowski, Roger
    [J]. UROLOGY, 2019, 127 : 1 - 8
  • [2] Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder
    Wang, Jipeng
    Zhou, Zhongbao
    Cui, Yuanshan
    Li, Yongwei
    Yuan, Hejia
    Gao, Zhenli
    Zhu, Zhe
    Wu, Jitao
    [J]. NEUROUROLOGY AND URODYNAMICS, 2019, 38 (01) : 22 - 30
  • [3] Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta-analysis
    He, Wenjuan
    Zhang, Yuqian
    Huang, Guangliang
    Tian, Yunfei
    Sun, Qian
    Liu, Xiuju
    [J]. LUTS-LOWER URINARY TRACT SYMPTOMS, 2023, 15 (03) : 80 - 88
  • [4] Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis
    Kelleher, Con
    Hakimi, Zalmai
    Zur, Richard
    Siddiqui, Emad
    Maman, Khaled
    Aballea, Samuel
    Nazir, Jameel
    Chapple, Chris
    [J]. EUROPEAN UROLOGY, 2018, 74 (03) : 324 - 333
  • [5] Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis
    Drake, Marcus J.
    Nitti, Victor W.
    Ginsberg, David A.
    Brucker, Benjamin M.
    Hepp, Zsolt
    McCool, Rachael
    Glanville, Julie M.
    Fleetwood, Kelly
    James, Daniel
    Chapple, Christopher R.
    [J]. BJU INTERNATIONAL, 2017, 120 (05) : 611 - 622
  • [6] RE: Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder
    Zhou, Zhongbao
    Gao, Zhenli
    [J]. NEUROUROLOGY AND URODYNAMICS, 2019, 38 (06) : 1792 - 1792
  • [7] Efficacy and safety of combinations of mirabegron and solifenacin in patients with overactive bladder: a systematic review and meta-analysis
    Peng, Liao
    Zeng, Xiao
    Shen, Hong
    Luo, De-Yi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (02): : 1355 - 1365
  • [8] Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
    Xu, Yankai
    Liu, Ruihua
    Liu, Chu
    Cui, Yuanshan
    Gao, Zhenli
    [J]. INTERNATIONAL NEUROUROLOGY JOURNAL, 2017, 21 (03) : 212 - 219
  • [9] Comparisons of the therapeutic safety of seven oral antimuscarinic drugs in patients with overactive bladder: a network meta-analysis
    Yang, Nannan
    Wu, Qiaoyan
    Xu, Faren
    Zhang, Xiaopeng
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (09)
  • [10] Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder
    Su, Shunye
    Hang, Liqin
    Lin, Jinlei
    Liu, Ludong
    Chen, Zhipeng
    Gao, Yuan
    [J]. MEDICINE, 2021, 100 (05) : E23171
12345